Because the
patient is not required to make frequent visits to a Hemodialysis clinic, a patient on
Peritoneal Dialysis may experience much less disruption to life than a patient on Hemodialysis.
However, the risk of infections leading to episodes of peritonitis, a bacterial infection
of the peritoneum, can limit Peritoneal Dialysis. In addition, patients using Peritoneal
Dialysis must have some residual renal function. Both factors limit Peritoneal Dialysis as
a long-term therapy for some patients. Therefore, in general, patients with end-stage
renal disease require Hemodialysis treatment at some point during the course of their
disease.
Hemodialysis is the more
frequently used treatment; approximately 85% of the worldwide patient population are
treated with Hemodialysis while 15% are on Peritoneal Dialysis. Yet, depending on different factors
such as status of the medical infrastructure and reimbursement differences for treatment,
there are significant differences in the utilization of Hemodialysi s and Peritoneal Dialysis in various countries. |